- Home
- TCRX vs CCLD Comparison
TCRX vs CCLD Comparison
Compare TCRX & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCRX
- CCLD
- Stock Information
- Founded
- TCRX 2018
- CCLD 1999
- Country
- TCRX United States
- CCLD United States
- Employees
- TCRX N/A
- CCLD N/A
- Industry
- TCRX Biotechnology: Pharmaceutical Preparations
- CCLD Computer Software: Prepackaged Software
- Sector
- TCRX Health Care
- CCLD Technology
- Exchange
- TCRX Nasdaq
- CCLD Nasdaq
- Market Cap
- TCRX 140.7M
- CCLD 146.0M
- IPO Year
- TCRX 2021
- CCLD 2014
- Fundamental
- Price
- TCRX $1.89
- CCLD $3.04
- Analyst Decision
- TCRX Strong Buy
- CCLD Buy
- Analyst Count
- TCRX 5
- CCLD 2
- Target Price
- TCRX $9.40
- CCLD $3.00
- AVG Volume (30 Days)
- TCRX 656.4K
- CCLD 379.9K
- Earning Date
- TCRX 11-07-2025
- CCLD 11-06-2025
- Dividend Yield
- TCRX N/A
- CCLD N/A
- EPS Growth
- TCRX N/A
- CCLD N/A
- EPS
- TCRX N/A
- CCLD 0.00
- Revenue
- TCRX $6,961,000.00
- CCLD $111,794,000.00
- Revenue This Year
- TCRX $255.18
- CCLD $6.94
- Revenue Next Year
- TCRX N/A
- CCLD $18.66
- P/E Ratio
- TCRX N/A
- CCLD $7,493.49
- Revenue Growth
- TCRX N/A
- CCLD 0.04
- 52 Week Low
- TCRX $1.02
- CCLD $1.14
- 52 Week High
- TCRX $6.23
- CCLD $4.84
- Technical
- Relative Strength Index (RSI)
- TCRX 39.56
- CCLD 40.07
- Support Level
- TCRX $1.74
- CCLD $2.97
- Resistance Level
- TCRX $2.43
- CCLD $3.11
- Average True Range (ATR)
- TCRX 0.18
- CCLD 0.16
- MACD
- TCRX -0.07
- CCLD -0.03
- Stochastic Oscillator
- TCRX 14.46
- CCLD 14.29
About TCRX TScan Therapeutics Inc.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
About CCLD CareCloud Inc.
CareCloud Inc delivers flexible, tech-enabled solutions for healthcare providers of all sizes and multi-specialties across the U.S. It is a healthcare technology company offering cloud-based solutions that simplify clinical, administrative, and financial workflows for medical practices of all sizes. Its comprehensive suite includes Electronic Health Records (EHRs), Practice Management, Revenue Cycle Management (RCM), Medical Billing, Telehealth, and Patient Experience solutions. The group helps practices increase efficiency, improve patient care, and drive sustainable growth-all while ensuring HIPAA compliance and seamless integration. The operating segments of the group are Healthcare IT, which is the key revenue-generating segment, and Medical Practice Management.